Ernexa Therapeutics (ERNAW) Gross Margin Growth (3y) (2013 - 2023)
Powered by 
Analysis
Ernexa Therapeutics (ERNAW) Gross Margin Growth (3y) (2013 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -230.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -168.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -65.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 14,836.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 589.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 53.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 569.00 |
| 10 | Ernexa Therapeutics | 67,312.70 | 67,312.70 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -14,783.00 |
| Sep 30, 2023 | -18,106.00 |
| Dec 31, 2020 | -1,928.00 |
| Sep 30, 2020 | -2,462.00 |
| Mar 31, 2020 | -445.00 |
| Dec 31, 2019 | -2,195.00 |
| Sep 30, 2019 | 275.00 |
| Jun 30, 2019 | 118.00 |
| Mar 31, 2019 | 643.00 |
| Dec 31, 2018 | 1,666.00 |
| Sep 30, 2018 | 1,735.00 |
| Jun 30, 2018 | 2,028.00 |
| Mar 31, 2018 | 1,212.00 |
| Dec 31, 2017 | 1,979.00 |
| Sep 30, 2017 | 796.00 |
| Jun 30, 2017 | 1,143.00 |
| Mar 31, 2017 | 419.00 |
| Dec 31, 2016 | 569.00 |
| Sep 30, 2016 | -437.00 |
| Jun 30, 2016 | -719.00 |